{
  "ptid_time": "072_S_2093_2011-04-15",
  "img_path": "/data/qiuhui/data/adni/images/072_S_2093/2011-04-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 19,051 mm³, 14.7% below the reference mean. With a Z-score of -0.37 (35.6th percentile), this represents normal volume ; hippocampal volume measures 8,370 mm³, 8.9% above the reference mean. With a Z-score of 1.00 (84.2th percentile), this represents mild enlargement; whole brain volume measures 1,052,650 mm³, 2.3% above the reference mean. With a Z-score of 0.28 (61.2th percentile), this represents normal volume ; entorhinal cortex volume measures 2,848 mm³, 26.8% below the reference mean. With a Z-score of -2.08 (1.9th percentile), this represents significant atrophy; fusiform gyrus volume measures 18,271 mm³, 0.3% above the reference mean. With a Z-score of 0.04 (51.5th percentile), this represents normal volume ; middle temporal gyrus volume measures 23,421 mm³, 14.1% above the reference mean. With a Z-score of 1.26 (89.6th percentile), this represents mild enlargement. ",
  "text_data": "Age is 60.0 years. Gender is Female. Education: 16 years. MMSE: 29.0. MoCA: 21.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The entorhinal cortex shows significant atrophy (Z-score -2.08, 1.9th percentile), which is a strong biomarker for early Alzheimer's pathology. Despite normal hippocampal and whole brain volumes, the MoCA score of 21 suggests cognitive impairment, while the MMSE of 29 is borderline normal, indicating possible early-stage decline. The presence of one APOE4 allele further increases Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype due to entorhinal atrophy and MoCA score).  \n\n**Confidence:** **Medium** (clinical and imaging findings align with MCI, but the discrepancy between MMSE and MoCA warrants caution).  \n\n*Note:* The entorhinal atrophy is highly suggestive of early Alzheimer's pathology, but the absence of hippocampal atrophy and relatively preserved global cognition (MMSE) prevent a definitive dementia diagnosis at this stage. Follow-up with CSF biomarkers or amyloid PET could clarify progression risk.",
  "timestamp": "2025-07-26T09:13:00.951403"
}